Global Proteomics Reagents Market Research Report
- Report Code: PR 1000
- Publish Date: Upcoming
The global proteomics reagents market is driven by the increase in collaboration between companies & research institutes and the increasing investments in R&D in this sector. The market was valued at $3.55 billion in 2012, and is expected to reach $6.59 billion by 2018, at a CAGR of 10.80%.
The report ‘Global proteomics reagents Market Forecast, 2012-2018’ analyzes the market in terms of product type, such as immunoassay, microarray, spectroscopy, electrophoresis, x-ray crystallography, chromatography, and protein fractionation. These market segments have experienced high growth, owing to an increased awareness for sophisticated diagnostic techniques. The immunoassay segment accounted for the largest share of 34.70% in the overall market, followed by microarray. The protein fractionation market is expected to grow at the fastest CAGR of 14.60%, during the forecast period.
In North America, funding for proteomics research from various organizations, increasing agreements and collaboration among large companies, and the increasing investments in R&D are the major driving factors for the proteomics reagents market.
Europe accounted for the second-largest share in the global proteomics reagents market. Huge capital investments are required for proteomics research. The governments in various European countries are allocating thematic priorities, and numerous organizations are putting in efforts to nurture the growth of the market. Non-profit organizations were established to coordinate national activities in the proteomics field, and numerous companies collaborated for proteomics research.
The report provides an extensive competitive landscaping of the leading companies operating in this market. The key players of the market covered in this report are Thermo Fisher Scientific, Life Technologies, Sigma- Aldrich Corporation, and Bio-Rad laboratories.
Furthermore, the details of the segment and country-specific company shares, news and deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies are provided in the report.
Customization Options
Along with the market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a deep-dive analysis of the following parameters:
Product Analysis:
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment levels
- Applications of the products (segment-wise and country-wise)
- A comprehensive coverage of product approvals, pipeline products, and product recalls
Key Data:
- Units reagents sold in a particular region
- The number of diagnostics labs, research labs, and hospitals where the proteomics reagents are used
Researcher/Scientist’s Perception Analysis:
- Fast turn-around analysis of researchers’ response to market events and trends
- Pattern analysis of usage by researchers
- Researchers’ opinions about products from different companies
Product/Brand Perception Matrix:
- Comprehensive study of customers’ perception and behavior through our in-built social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution
Pricing Trends:
- Cost analysis of proteomics reagents in the major countries
Competitive Intelligence:
- The company share analysis of the top players in the market
- The crucial developments and strategies that companies inculcate in their portfolios
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Proteomics Reagents The North American proteomics reagents market is driven by the increase in collaboration between companies and research Institutes and increasing R&D investments in research. The value of the proteomics market was $ 1.34 million in 2012, and is expected to reach $ 2.26 billion by 2018, at a CAGR of 8.2%. The report “North American proteomics reagents Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Immunoassay, Microarray, Spectroscopy, Electrophoresis, X-ray Crystallography, Chromatography and Protein Fractionation. The key players of the market covered in this report are Thermo Fisher Scientific, Life Technologies, Sigma- Aldrich Corporation and Bio-Rad laboratories. |
Upcoming |
|
|
European Proteomics Reagents The European proteomics reagent market is driven by the increase in collaboration between companies and research Institutes and increasing R&D investments in research. The value of the proteomics market was $ 1.23 billion in 2012, and is expected to reach $ 2.23 billion by 2018, at a CAGR of 10.3%. The report “European proteomics reagent Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Immunoassay, Microarray, Spectroscopy, Electrophoresis, X-ray Crystallography, Chromatography and Protein Fractionation. The key players of the market covered in this report are Thermo Fisher Scientific, Life Technologies, Bio-Rad laboratories, etc. |
Upcoming |
|
|
Asian Proteomics Reagents The Asian proteomics reagents market is driven by the increase in collaboration between companies and research Institutes and increasing R&D investments in research. The value of the proteomics market was $ 541 million in 2012, and is expected to reach $ 12.6 million by 2018, at a CAGR of 15.3%. The report “Asia proteomics reagent Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Immunoassay, Microarray, Spectroscopy, Electrophoresis, X-ray Crystallography, Chromatography and Protein Fractionation. The key players of the market covered in this report are Thermo Fisher Scientific, Life Technologies Corporation, Bio-Rad laboratories, Agilent technologies, GE Healthcare, etc. |
Upcoming |
